Inve India ▾

Cyient DLM share price & results

Cyient DLM· Capital Goods· Industrials

Results to
Sept 2026
Latest analysed call
Q2 FY27
Ownership as of
Sept 2026

Design-led EMS maker of PCBAs, cable harnesses, box builds for aerospace, defence, medical, industrial OEMs

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue393 ₹ crore+26.4% YoYQuarterly, as filedQuarter to Sept 2026Revenue from operations as filed.
Operating margin9.0 %−1.0 pts YoYOperating profit / revenueQuarter to Sept 2026For the quarter; a change is in percentage points.
Net profit34.0 ₹ crore+6.3% YoYQuarterly, as filedQuarter to Sept 2026Profit after tax as filed.
Return on equity7.77 %+0.1 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin0.71 %+8.1 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)-1.51 %−44.6 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Sept 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Sept 2026

Guidance

What management said, and what became of it

2 of 9 judged targets kept · 16 open · verdicts reflect calls analysed to Q2 FY27.

Cyient DLM management guidance track record on Inve: 25 targets tracked across analysed earnings calls (2 achieved, 7 missed, 16 open).

TargetOriginal wordingSaidLatest callVerdict
Overall EBITDA MarginConsistently deliver 10% EBITDA margin
Call transcript, Q3 FY25 · 21 Jan 2025
Q3 FY25Q2 FY27:Promise was previously achieved after three consecutive quarters above 10%. The metric dipped to 8.7% this quarter, but the original milestone is considered complete. Ongoing performance is tracked by newer promises.
Call transcript, Q2 FY27 · 15 Oct 2026
Achieved
FY26 Revenue GrowthA good year ahead in FY26 (after a soft start)
Call transcript, Q4 FY25 · 22 Apr 2025
Q4 FY25Q2 FY27:Promise pertains to FY26, which has concluded. The promise was missed.
Call transcript, Q2 FY27 · 15 Oct 2026
Missed
FY27 Revenue Growth20% to 25%
Call transcript, Q3 FY26 · 20 Jan 2026
Q3 FY26Q2 FY27:H1 FY27 growth was 30.2% YoY. Management explicitly guided for 30-35% growth for the full year FY27, raising the target from the original 20-25% range.
Call transcript, Q2 FY27 · 15 Oct 2026
Revised Up

Source: Inve Guidance Tracker for Cyient DLM · to Q2 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

7 of Cyient DLM's 25 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 22 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹758.55 +1.37% · +₹10.25

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance +68.2% 1Y

₹0.4k₹0.6k₹0.8k₹1.0kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q3 FY26 — 20 Jan 2026Q4 FY26 — 21 Apr 2026Q1 FY27 — 21 Jul 2026Q2 FY27 — 15 Oct 2026

1Y: ₹450.85 on 24 Oct 2025 → ₹758.55. High ₹1,038.55 (14 Oct 2026), low ₹272.3 (30 Mar 2026).

Previous close
₹748.3
Market cap
₹6.0k Cr
52-week range
₹272.3 – ₹1,038.55
One year
+68.57%
Price to earnings (TTM to Sept 2026)
72.07×
Return on equity (TTM to Sept 2026)
7.77%

Overview

Symbol
NSE:CYIENTDLM
Industry
Industrials
Exchange
NSE
Currency
INR

What Cyient DLM does

Based on the company's own presentations, annual report and earnings calls.

Cyient DLM (a subsidiary of Cyient Ltd) is an electronics manufacturing services (EMS) provider that builds high-mix, high-reliability electronics and mechanical assemblies for OEMs in safety- and mission-critical industries. It designs and manufactures printed circuit board assemblies (PCBA), cable harness assemblies, box builds/system integration, and precision-machined parts, taking products from design-for-manufacturability through prototyping, production and end-of-life support. Its clients are largely 'A-list' original equipment manufacturers in aerospace, defence, medical/healthcare, industrial and automotive electronics, sourced through a global supply chain of vendors. It holds a leading position by value in India's Aerospace & Defence EMS market, and expanded into North America in FY25 by acquiring Connecticut-based Altek Electronics.

Segments

  • Aerospace & Defence
  • Industrial
  • Medical & Healthcare
  • Automotive
  • Others (incl. Telecom, Rail, B2S)
Manufacturing facilities
5: Mysuru + Mysuru Expansion, Hyderabad (SEZ), Bengaluru (India) and Torrington, Connecticut (USA, via Altek Electronics)
Total manufacturing area
~4.45 lakh sq ft (Hyderabad 1,70,000 sq ft; Mysuru 1,15,000 + 43,400 sq ft; USA 81,000 sq ft; Bengaluru 36,000 sq ft)
Associates (workforce)
1,600+ (FY25 annual report)
Track record
30+ years in design-led electronics and mechanical manufacturing
Supplier network
700+ vendors in global supply chain
Market position
Leading EMS provider by value in India's Aerospace & Defence segment
Founded 1993Headquarters Plot No. 5G, Survey No. 99/1, Mamidipalli Village, GMR Aerospace & Industrial Park, Rajiv Gandhi International Airport, Shamshabad, Hyderabad - 500108, Telangan Company website

How the price took the results

close before → close after

Q2 FY27
−0.8%
15 Oct
Q1 FY27
+4.5%
21 Jul
Q4 FY26
+3.5%
21 Apr
Q3 FY26
−4.7%
20 Jan

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Cyient DLM

Free account: one company. Everything above stays public.

Write why you follow Cyient DLM and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds